购物车
- 全部删除
- 您的购物车当前为空
Kanzonol C has antimicrobial activity, it also shows potent PTP1B inhibitory activity (IC50 value of 0.31-0.97uM). Kanzonol C has chemopreventive activity,it shows the inhibition of matrix metalloproteinase (MMP)-2 secretion from brain tumor-derived glioblastoma cells.
Kanzonol C has antimicrobial activity, it also shows potent PTP1B inhibitory activity (IC50 value of 0.31-0.97uM). Kanzonol C has chemopreventive activity,it shows the inhibition of matrix metalloproteinase (MMP)-2 secretion from brain tumor-derived glioblastoma cells.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 5,250 | 5日内发货 | |
1 mL x 10 mM (in DMSO) | ¥ 6,300 | 5日内发货 |
产品描述 | Kanzonol C has antimicrobial activity, it also shows potent PTP1B inhibitory activity (IC50 value of 0.31-0.97uM). Kanzonol C has chemopreventive activity,it shows the inhibition of matrix metalloproteinase (MMP)-2 secretion from brain tumor-derived glioblastoma cells. |
体外活性 | Based on the bioactivities of licorice, these compounds were screened using cell- or enzyme-based bioassay methods. A total of 11 compounds exhibited potent cytotoxic activities against three human cancer cell lines (HepG2, SW480 and MCF7), while showed little toxicity on human normal cell lines LO2 and HEK293T. A number of chalcones showed remarkable anti-inflammatory activities. Among them, 2 (licochalcone B, IC50 8.78μM), 10 (licoagrochalcone C, IC50 9.35μM) and 13 (licochalcone E, IC50 9.09μM) exhibited the most potent inhibitory activities on LPS-induced NO production, whereas 1, 8, 10, 12 and 13 (IC50 13.9, 7.27, 2.44, 6.67 and 3.83μM) showed potent inhibitory activities on NF-κB transcription[1] |
分子量 | 392.49 |
分子式 | C25H28O4 |
CAS No. | 151135-82-9 |
密度 | 1.165 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
中药材名称 | 中药材拉丁名 | 性 | 味 | 归经 |
---|---|---|---|---|
光果甘草 | Radix Glycyrrhizae Glabrae | 平 | 甘 | 心, 肺, 脾, 胃 |
中成药名称 | 处方组成 | 中成药类型 |
---|
方剂名称 | 处方组成 | 剂型 | 处方来源 |
---|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容